GeneOne Life Science, Inc. Logo

GeneOne Life Science, Inc.

Develops nucleic acid vaccines & therapies for infectious diseases, cancer & autoimmune disorders.

011000 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 여의대로 108 20층(여의도동, 파크원NH금융타워(타워2)), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GeneOne Life Science, Inc. is a biotechnology research and development company specializing in nucleic acid-based biomedicines. The company focuses on developing DNA and mRNA vaccines to combat emerging infectious diseases, nucleic acid therapeutics such as plasmid-encoded monoclonal antibodies (Plas-mAbs®) and recombinant proteins for conditions like cancer and autoimmune disorders, and immunomodulatory small molecule drugs. Its core technologies include a DNA plasmid delivery platform designed as a potential alternative to viral vectors. Leveraging its subsidiary, VGXI, GeneOne has capabilities for large-scale cGMP manufacturing of its gene-based medicines to support global health initiatives.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for GeneOne Life Science, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-09 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 13.6 KB
2025-09-08 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 15.9 KB
2025-09-04 00:00
Share Issue/Capital Change
소액공모실적보고서
Korean 25.7 KB
2025-09-04 00:00
Share Issue/Capital Change
유상증자또는주식관련사채등의발행결과(자율공시)
Korean 7.5 KB
2025-09-03 00:00
Share Issue/Capital Change
유상증자또는주식관련사채등의청약결과(자율공시)
Korean 7.1 KB
2025-08-29 00:00
Prospectus
소액공모공시서류(지분증권)
Korean 1.9 MB
2025-08-29 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 49.7 KB
2025-08-29 00:00
Share Issue/Capital Change
유상증자신주발행가액(안내공시)
Korean 4.2 KB

Automate Your Workflow. Get a real-time feed of all GeneOne Life Science, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GeneOne Life Science, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
KANABO GROUP PLC Logo
Develops cannabis formulas and vaporization devices for the medical and consumer wellness markets.
United Kingdom KNB
Kancera Logo
Develops small molecule drugs targeting the fractalkine axis for cancer and inflammatory diseases.
Sweden KAN
KANGSTEM BIOTECH CO., LTD. Logo
Develops stem cell therapies for rare diseases; offers culture media, cell platforms, and CDMO services.
South Korea 217730
Karo Pharma AB Logo
Develops and sells everyday healthcare products, focusing on OTC and skin health in Europe.
Sweden KARO
KBIO COMPANY Inc. Logo
Using a plant-based platform to rapidly develop biologics for public health.
South Korea 038530
Keeps Biopharma Inc. Logo
Develops cancer therapies and obesity drugs; manufactures industrial and cleanroom products.
South Korea 256940
Kidswell Bio Corporation Logo
Biopharma R&D of biosimilars, biologics, and cell therapies, with a pediatric focus.
Japan 4584
Kinarus Therapeutics Holding AG Logo
A specialty pharma firm developing and selling medicines for rare and specialty diseases.
Switzerland KNRS
KISSEI PHARMACEUTICAL CO.,LTD. Logo
Develops innovative drugs for urology, renal diseases, and rare or intractable diseases.
Japan 4547
Klaria Pharma Holding AB Logo
Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.
Sweden KLAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.